Cargando…
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor-mediated ex vivo platelet function in ST-elevation and non-ST-elevation acute myocardial infarction
Autores principales: | Spiel, Alexander O, Mayr, Florian B, Ladani, Nathalie, Merlino, Patricia G, Schaub, Robert, Gilbert, Jim, Jilma, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313246/ http://dx.doi.org/10.1186/1471-2210-8-S1-A54 |
Ejemplares similares
-
Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200
por: Zhu, Shuhao, et al.
Publicado: (2020) -
Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
por: Sakai, Kazuya, et al.
Publicado: (2019) -
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
por: Kovacevic, Katarina D., et al.
Publicado: (2021) -
Non-ST-Elevation Myocardial Infarction in a Case of Von Willebrand Disease: a Case Report
por: Abdul, Anees, et al.
Publicado: (2018) -
The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer
por: Zhu, Shuhao, et al.
Publicado: (2020)